| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 489 |
| 1 | METHOTREXATE | 403 |
| 2 | CYTARABINE | 300 |
| 3 | DEXAMETHASONE | 199 |
| 4 | DEXAMETHASONE 1.5 MG | 199 |
| 5 | CYCLOPHOSPHAMIDE | 182 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 182 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 182 |
| 8 | PREDNISONE | 132 |
| 9 | PREDNISOLONE | 123 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBUPROFEN AND FAMOTIDINE | 1 | 0.0909 |
| 1 | NELARABINE | 52 | 0.0534 |
| 2 | CAMPHOR, MENTHOL, METHYL SALICYLATE | 1 | 0.0204 |
| 3 | NITROUS OXIDE | 30 | 0.0135 |
| 4 | PRALATREXATE | 8 | 0.0123 |
| 5 | AMPHETAMINE SULFATE TABLETS | 17 | 0.0098 |
| 6 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 7 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 8 | CASTOR OIL | 1 | 0.0052 |
| 9 | CYTARABINE | 300 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 491 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 404 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 353 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 211 |
| 4 | Alkylating Drug [EPC] | 210 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 144 |
| 6 | Benzodiazepine [EPC] | 135 |
| 7 | Loop Diuretic [EPC] | 96 |
| 8 | Partial Opioid Agonist [EPC] | 88 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 13 | 0.0043 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 31 | 0.0023 |
| 2 | Methylating Agent [EPC] | 2 | 0.0019 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 14 | 0.0014 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 353 | 0.0013 |
| 5 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 6 | Partial Opioid Agonist [EPC] | 88 | 0.0009 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 404 | 0.0009 |
| 8 | Benzothiazole [EPC] | 2 | 0.0009 |
| 9 | Topoisomerase Inhibitor [EPC] | 68 | 0.0009 |